Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2007
12/19/2007EP1865921A1 Pharmaceutical preparation of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide
12/19/2007EP1865775A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
12/19/2007EP1865774A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/19/2007EP1740538A4 Bicyclic heterocycles useful as serine protease inhibitors
12/19/2007EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
12/19/2007EP1546152B1 Epothilone derivatives
12/19/2007EP1539713B1 Pyrimidine derivatives as modulators of chemokine receptor activity
12/19/2007EP1422224B1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
12/19/2007CN101090900A Process for preparation of high-purity meloxicam and meloxicam potassium salt
12/19/2007CN101090899A 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
12/19/2007CN101090898A 5-HT7 receptor antagonists
12/19/2007CN101088998A Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same
12/19/2007CN100355758C Guanidine derivatives and use thereof as neuropeptide FF receptor antagonists
12/19/2007CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
12/19/2007CN100355739C Diazosulfide derivative, and its synthesizing method and activity for inducing tobacco to resist tobacco mosaic virus
12/19/2007CN100355728C Inhibitors of dipeptidyl peptidase IV
12/18/2007US7309709 And oxazole sulfonamides: 3-(2-{1-[(4-Chloro-benzenesulfonyl)-(2,5-difluoro-phenyl)-amino]-ethyl}-thiazol-5-yl)-propionic acid, 4-Chloro-N-(2,5-difluoro-phenyl)-N-[1-(4-methyl-5-{[3-(2-oxo-pyrrolidin-1-yl)-propylamino]-methyl}-thiazol-2-yl)-ethyl]-benzenesulfonamide; Alzheimer's disease
12/18/2007US7309708 Serine protease inhibition via N-(distubstituted aminomethylcarbonyl)-2-[N-(1-sulfonylamido-1-cyclopropanyl)amido]pyrrolidines
12/18/2007US7309704 Piperidinyl- and pyrimidinyl-ureas: N-(1-acetyl-4-piperidinyl)-N-methyl-N'-(5-(3,5-difluorophenyl)-2-pyrimidinyl)urea; metabolic disorders, eating disorders, disorders associated with obesity: type II diabetes, insulin resistance, hyperlipidemia or hypertension.
12/18/2007US7309701 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example
12/13/2007WO2007141039A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/13/2007WO2007111904A3 C-met protein kinase inhibitors for the treatment of proliferative disorders
12/13/2007US20070287737 Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors
12/13/2007US20070287703 Fused Pyrimidones Useful in the Treatment and the Prevention of Cancer
12/13/2007US20070287696 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
12/13/2007CA2653655A1 Organic compounds
12/13/2007CA2653526A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/12/2007EP1864983A1 Pyrimidine compounds as cyclin-dependent kinase inhibitors
12/12/2007EP1864981A1 Thrombopoietin mimetics
12/12/2007EP1864979A1 Imidazole-derivatives as TAFAIa-inhibitors
12/12/2007EP1864975A2 Novel compounds
12/12/2007EP1863833A2 Process for preparing macrocyclic compounds
12/12/2007EP1863807A1 'n-(2-chloro-6-methylphenyl)-2-ýý6-ý4-(2-hydroxyethyl)-1-piperazinyl¨-2-methyl-4-pyrimidinyl¨amino¨-5-thiazolecarboxamides metabolites
12/12/2007EP1863806A1 Amorphous ziprasidone mesylate
12/12/2007EP1863805A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
12/12/2007EP1863804A1 Inhibitors of histone deacetylase
12/12/2007EP1863785A1 Novel thiophene sulfoximines for treating cmplement-mediated deseases and conditions
12/12/2007EP1863771A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
12/12/2007EP1863483A1 Bicyclic pyrazole compounds as antibacterial agents
12/12/2007EP1644357B1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/12/2007EP1399443B1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
12/12/2007CN101087785A 4-methoxy-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors
12/12/2007CN101087784A Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
12/12/2007CN101087781A Indole derivatives for treating pulmonary tuberculosis
12/12/2007CN101087768A Thrombopoietin activity modulating compounds and methods
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007CN101085774A Pidodela prepared from delavirdine intermediate and pidotimod, and synthetic method
12/12/2007CN101085769A Method for synthesizing alpha-pyranone derivatives
12/12/2007CN100354273C Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/12/2007CN100354263C Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
12/11/2007US7307163 Process for the preparation of linezolid and related compounds
12/11/2007US7307095 Osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis, (S)-2-(Benzooxazol-2-ylamino)-3-cyclohexyl-N-[2-(5-fluoro-2,3-dihydro-indol-1-yl)-ethyl]-propionamide
12/11/2007US7307088 Substituted anthranilic amide derivatives and methods of use
12/11/2007US7307086 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/11/2007US7307077 Heterocyclic compound and antitumor agent containing the same as effective ingredient
12/11/2007US7307075 Tetrahydroquinoline analogues as muscarinic agonists
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007WO2007140439A2 Compounds as cannabinoid receptor ligands and uses thereof
12/06/2007WO2007140197A1 Therapeutic pyrrolidine compounds
12/06/2007WO2007140183A1 Fxr agonists
12/06/2007WO2007139955A2 Triazole compounds that modulate hsp90 activity
12/06/2007WO2007138994A1 Hsp90 inhibitor
12/06/2007WO2007138242A1 Biphenyl derivatives and their use in treating hepatitis c
12/06/2007WO2007137980A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007WO2007137962A1 Thiazole derivatives
12/06/2007WO2007137954A1 Aryl-4-ethynyl-isoxazole derivatives
12/06/2007WO2007137791A1 Aryl-substituted heterocycles, and use thereof
12/06/2007WO2007137417A1 Heterocyclic compounds as calcium channel blockers
12/06/2007WO2007079186A3 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors
12/06/2007WO2006067428A3 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands
12/06/2007US20070281946 Tri(cyclo) substituted amide compounds
12/06/2007US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1
12/06/2007US20070281936 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide
12/06/2007US20070281930 bicyclic bisamides for controlling acarina
12/06/2007US20070281921 Piperidinyl pyrimidine derivatives
12/06/2007US20070281920 5-(1H-indol-5-yl)-2-methyl-2,3,4,5-tetrahydro-1H-benzo[c]azepine; for treatment of monoamine reuptake inhibitor-mediated diseases such as depression, anxiety, genitourinary disorders and pain
12/06/2007US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands
12/06/2007US20070281363 Luminescent compounds
12/06/2007US20070281343 Recombinant Myxococcus host cells used to produce polyketides, including epothilone and epothilone analogs; agriculture, chemistry, medicinal chemistry, medicine, molecular biology, and pharmacology
12/06/2007DE102007019022A1 Farbstoff für farbstoffsensibilisierte Solarzelle und daraus hergestellte Solarzelle Dye for dye-sensitized solar cell and solar cell made therefrom
12/06/2007CA2653924A1 Biphenyl derivatives and their use in treating hepatitis c
12/06/2007CA2653497A1 Heterocyclic compounds as calcium channel blockers
12/06/2007CA2653319A1 Hsp90 inhibitor
12/06/2007CA2653223A1 Therapeutic pyrrolidine compounds
12/06/2007CA2653222A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2652636A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007CA2652162A1 Thiazole derivatives
12/06/2007CA2651857A1 Aryl-4-ethynyl-isoxazole derivatives
12/06/2007CA2647598A1 Compounds as cannabinoid receptor ligands and uses thereof
12/06/2007CA2647597A1 Thiazole compounds as cannabinoid receptor ligands and uses thereof
12/05/2007EP1862464A1 Novel cyclic aminophenylalkanoic acid derivative
12/05/2007EP1862458A2 Therapeutic agents useful for treating pain
12/05/2007EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1861396A1 Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
12/05/2007EP1861395A1 5-(1,3-diaryl-1h-pyrazol-4-ylmethylene)-thiazolidine-2,4-dione derivatives useful as anticancer agent
12/05/2007EP1861393A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/05/2007EP1861390A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/05/2007EP1861377A1 Benzimidazolone derivatives as cb2 receptor ligands
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 628